T1	DrugClass 27 32	GBCAs
T2	AdverseReaction 70 73	NSF
T3	AdverseReaction 119 122	NSF
T4	Negation 127 130	not
T5	AdverseReaction 212 238	Hypersensitivity reactions
T6	AdverseReaction 243 262	acute kidney injury
T7	AdverseReaction 458 464	nausea
T8	AdverseReaction 466 474	headache
T9	AdverseReaction 476 495	injection site pain
T10	AdverseReaction 497 520	injection site coldness
T11	AdverseReaction 526 543	burning sensation
T12	AdverseReaction 1832 1838	Nausea
T13	AdverseReaction 1939 1947	Headache
T14	AdverseReaction 2046 2065	Injection Site Pain
T15	AdverseReaction 2153 2176	Injection Site Coldness
T16	AdverseReaction 2260 2277	Burning Sensation
T17	AdverseReaction 2476 2488	feeling cold
T18	AdverseReaction 2490 2494	rash
T19	AdverseReaction 2496 2506	somnolence
T20	AdverseReaction 2508 2515	fatigue
T21	AdverseReaction 2517 2526	dizziness
T22	AdverseReaction 2528 2536	vomiting
T23	AdverseReaction 2538 2546	pruritus
T24	AdverseReaction 2548 2559	paresthesia
T25	AdverseReaction 2561 2570	dysgeusia
T26	AdverseReaction 2572 2589	pain in extremity
T27	AdverseReaction 2591 2598	anxiety
T28	AdverseReaction 2600 2612	hypertension
T29	AdverseReaction 2614 2626	palpitations
T30	AdverseReaction 2628 2652	oropharyngeal discomfort
T31	AdverseReaction 2654 2680	serum creatinine increased
T32	AdverseReaction 2685 2709	injection site reactions
T33	AdverseReaction 2685 2694;2721 2738	injection site reactions, including site inflammation
T34	AdverseReaction 2685 2699;2740 2753	injection site reactions, including site inflammation, extravasation
T35	AdverseReaction 2685 2699;2755 2763	injection site reactions, including site inflammation, extravasation, pruritus
T36	AdverseReaction 2685 2699;2769 2775	injection site reactions, including site inflammation, extravasation, pruritus, and warmth
T37	AdverseReaction 3138 3146	headache
T38	AdverseReaction 3827 3838	bradycardia
T39	AdverseReaction 3840 3851	tachycardia
T40	AdverseReaction 3853 3863	arrhythmia
T41	AdverseReaction 3934 3950	hypersensitivity
T42	AdverseReaction 3952 3975	anaphylactoid reactions
T43	AdverseReaction 3986 4000	cardiac arrest
T44	AdverseReaction 4002 4020	respiratory arrest
T45	AdverseReaction 4022 4030	cyanosis
T46	AdverseReaction 4031 4047	pharyngeal edema
T47	AdverseReaction 4049 4061	laryngospasm
T48	AdverseReaction 4063 4075	bronchospasm
T49	AdverseReaction 4077 4087	angioedema
T50	AdverseReaction 4089 4103	conjunctivitis
T51	AdverseReaction 4105 4121	ocular hyperemia
T52	AdverseReaction 4123 4135	eyelid edema
T53	AdverseReaction 4137 4158	lacrimation increased
T54	AdverseReaction 4160 4173	hyperhidrosis
T55	AdverseReaction 4175 4184	urticaria
T56	AdverseReaction 4233 4237	coma
T57	AdverseReaction 4239 4249	convulsion
T58	AdverseReaction 4251 4258	syncope
T59	AdverseReaction 4260 4270	presyncope
T60	AdverseReaction 4272 4280	parosmia
T61	AdverseReaction 4282 4288	tremor
T62	AdverseReaction 4349 4367	muscle contracture
T63	AdverseReaction 4369 4384	muscle weakness
T64	AdverseReaction 4456 4464	diarrhea
T65	AdverseReaction 4466 4489	salivary hypersecretion
T66	AdverseReaction 4577 4584	malaise
T67	AdverseReaction 4586 4591	fever
T68	AdverseReaction 4684 4687	NSF
T69	DrugClass 4755 4760	GBCAs
T70	Negation 4832 4834	No
T71	AdverseReaction 4857 4860	NSF
T72	AdverseReaction 4942 4963	superficial phlebitis
T73	AdverseReaction 5035 5064	NEPHROGENIC SYSTEMIC FIBROSIS
T74	AdverseReaction 5066 5069	NSF
T75	AdverseReaction 5083 5112	NEPHROGENIC SYSTEMIC FIBROSIS
T76	AdverseReaction 5114 5117	NSF
T77	DrugClass 5124 5156	Gadolinium-based contrast agents
T78	AdverseReaction 5187 5190	NSF
T79	AdverseReaction 5393 5396	NSF
T80	Factor 5397 5400	may
T81	AdverseReaction 5411 5416	fatal
T82	Severity 5420 5432	debilitating
T83	AdverseReaction 5433 5441	fibrosis
T84	Factor 5503 5507	risk
T85	AdverseReaction 5512 5515	NSF
T86	AdverseReaction 6182 6211	NEPHROGENIC SYSTEMIC FIBROSIS
T87	AdverseReaction 6213 6216	NSF
T88	DrugClass 6298 6330	Gadolinium-based contrast agents
T89	AdverseReaction 6361 6364	NSF
T90	Factor 6580 6584	risk
T91	AdverseReaction 6589 6592	NSF
T92	AdverseReaction 7058 7087	Nephrogenic Systemic Fibrosis
T93	AdverseReaction 7241 7257	Hypersensitivity
T94	AdverseReaction 7259 7272;7286 7295	Anaphylactoid/anaphylactic reactions
T95	AdverseReaction 7273 7295	anaphylactic reactions
T96	AdverseReaction 7301 7315;7342 7356	cardiovascular, respiratory or cutaneous manifestations
T97	AdverseReaction 7317 7328;7342 7356	respiratory or cutaneous manifestations
T98	AdverseReaction 7332 7356	cutaneous manifestations
T99	Severity 7371 7375	mild
T100	Severity 7379 7385	severe
T101	AdverseReaction 7397 7402	death
T102	DrugClass 7565 7597	Gadolinium-based contrast agents
T103	AdverseReaction 7628 7657	nephrogenic systemic fibrosis
T104	AdverseReaction 7659 7662	NSF
T105	DrugClass 7871 7875	GBCA
T106	AdverseReaction 7887 7890	NSF
T107	AdverseReaction 8244 8247	NSF
T108	Factor 8248 8251	may
T109	AdverseReaction 8262 8267	fatal
T110	Severity 8271 8283	debilitating
T111	AdverseReaction 8284 8292	fibrosis
T112	AdverseReaction 9881 9893;9912 9921	Anaphylactic and anaphylactoid reactions
T113	AdverseReaction 9898 9921	anaphylactoid reactions
T114	AdverseReaction 10053 10073	circulatory collapse
T115	AdverseReaction 10078 10082	died
T116	Factor 10411 10414	may
T117	AdverseReaction 10444 10469	hypersensitivity reaction
T118	AdverseReaction 10892 10911	acute kidney injury
T119	DrugClass 10960 10965	GBCAs
T120	AdverseReaction 11469 11483;11498 11515	administration may result in tissue irritation
T121	Factor 11484 11487	may
R1	Hypothetical arg1:T2 arg2:T1
R2	Negated arg1:T3 arg2:T4
R3	Hypothetical arg1:T68 arg2:T69
R4	Negated arg1:T71 arg2:T70
R5	Hypothetical arg1:T78 arg2:T77
R6	Hypothetical arg1:T81 arg2:T80
R7	Hypothetical arg1:T83 arg2:T80
R8	Effect arg1:T83 arg2:T82
R9	Hypothetical arg1:T85 arg2:T84
R10	Hypothetical arg1:T89 arg2:T88
R11	Hypothetical arg1:T91 arg2:T90
R12	Effect arg1:T96 arg2:T99
R13	Effect arg1:T96 arg2:T100
R14	Effect arg1:T97 arg2:T99
R15	Effect arg1:T97 arg2:T100
R16	Effect arg1:T98 arg2:T99
R17	Effect arg1:T98 arg2:T100
R18	Hypothetical arg1:T103 arg2:T102
R19	Hypothetical arg1:T104 arg2:T102
R20	Hypothetical arg1:T106 arg2:T105
R21	Hypothetical arg1:T107 arg2:T108
R22	Hypothetical arg1:T109 arg2:T108
R23	Hypothetical arg1:T111 arg2:T108
R24	Effect arg1:T111 arg2:T110
R25	Hypothetical arg1:T117 arg2:T116
R26	Hypothetical arg1:T118 arg2:T119
R27	Hypothetical arg1:T120 arg2:T121
N1	Reference T5 meddra:10020751	Hypersensitivity
N2	Reference T6 meddra:10069339	Acute kidney injury
N3	Reference T7 meddra:10028813	Nausea
N4	Reference T8 meddra:10019211	Headache
N5	Reference T9 meddra:10022086	Injection site pain
N6	Reference T10 meddra:10050082	Injection site coldness
N7	Reference T11 meddra:10006784	Burning sensation
N8	Reference T17 meddra:10016326	Feeling cold
N9	Reference T18 meddra:10037844	Rash
N10	Reference T19 meddra:10041349	Somnolence
N11	Reference T20 meddra:10016256	Fatigue
N12	Reference T21 meddra:10013573	Dizziness
N13	Reference T22 meddra:10047700	Vomiting
N14	Reference T23 meddra:10037087	Pruritus
N15	Reference T24 meddra:10033775	Paraesthesia
N16	Reference T25 meddra:10013911	Dysgeusia
N17	Reference T26 meddra:10033425	Pain in extremity
N18	Reference T27 meddra:10002855	Anxiety
N19	Reference T28 meddra:10020772	Hypertension
N20	Reference T29 meddra:10033557	Palpitations
N21	Reference T30 meddra:10068318	Oropharyngeal discomfort
N22	Reference T31 meddra:10005483	Blood creatinine increased
N23	Reference T32 meddra:10022095	Injection site reaction
N24	Reference T33 meddra:10022078	Injection site inflammation
N25	Reference T34 meddra:10022062	Injection site extravasation
N26	Reference T35 meddra:10022093	Injection site pruritus
N27	Reference T36 meddra:10022112	Injection site warmth
N28	Reference T38 meddra:10006093	Bradycardia
N29	Reference T39 meddra:10043071	Tachycardia
N30	Reference T40 meddra:10003119	Arrhythmia
N31	Reference T41 meddra:10020751	Hypersensitivity
N32	Reference T42 meddra:10002216	Anaphylactoid reaction
N33	Reference T43 meddra:10007515	Cardiac arrest
N34	Reference T44 meddra:10038669	Respiratory arrest
N35	Reference T45 meddra:10011703	Cyanosis
N36	Reference T46 meddra:10034829	Pharyngeal oedema
N37	Reference T47 meddra:10023891	Laryngospasm
N38	Reference T48 meddra:10006482	Bronchospasm
N39	Reference T49 meddra:10002424	Angioedema
N40	Reference T50 meddra:10010741	Conjunctivitis
N41	Reference T51 meddra:10030041	Ocular hyperaemia
N42	Reference T52 meddra:10015993	Eyelid oedema
N43	Reference T53 meddra:10023644	Lacrimation increased
N44	Reference T54 meddra:10020642	Hyperhidrosis
N45	Reference T55 meddra:10046735	Urticaria
N46	Reference T56 meddra:10010071	Coma
N47	Reference T57 meddra:10039906	Seizure
N48	Reference T58 meddra:10042772	Syncope
N49	Reference T59 meddra:10036653	Presyncope
N50	Reference T60 meddra:10034018	Parosmia
N51	Reference T61 meddra:10044565	Tremor
N52	Reference T62 meddra:10062575	Muscle contracture
N53	Reference T63 meddra:10028372	Muscular weakness
N54	Reference T64 meddra:10012735	Diarrhoea
N55	Reference T65 meddra:10039424	Salivary hypersecretion
N56	Reference T66 meddra:10025482	Malaise
N57	Reference T67 meddra:10037660	Pyrexia
N58	Reference T72 meddra:10034902	Phlebitis superficial
N59	Reference T73 meddra:10067467	Nephrogenic systemic fibrosis
N60	Reference T2 meddra:10067467	Nephrogenic systemic fibrosis
N61	Reference T81 meddra:10011906	Death
N62	Reference T83 meddra:10016642	Fibrosis
N63	Reference T95 meddra:10002198	Anaphylactic reaction
N64	Reference T96 meddra:10075534	Cardiovascular symptom
N65	Reference T97 meddra:10075535	Respiratory symptom
N66	Reference T98 meddra:10075531	Cutaneous symptom
N67	Reference T101 meddra:10011906	Death
N68	Reference T114 meddra:10009192	Circulatory collapse
N69	Reference T115 meddra:10011906	Death
N70	Reference T117 meddra:10020751	Hypersensitivity
N71	Reference T120 meddra:10075941	Administration site irritation
